Form 4: Rivian CEO Scaringe Exercises and Sells 200,000 Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Rivian CEO Robert J. Scaringe exercised options and sold 200,000 shares of Class A Common Stock at an average price of $18.0011, while also exercising options at $2.6282 per share.

Summary

  • Rivian Automotive, Inc. CEO Robert J. Scaringe executed transactions involving the company's Class A Common Stock on July 12, 2024.
  • Scaringe exercised options to acquire 200,000 shares at a price of $2.6282 per share.
  • Simultaneously, he sold 200,000 shares at a weighted average price of $18.0011, with individual sales ranging from $18.00 to $18.02.
  • These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 8, 2024.
  • Following these transactions, Scaringe directly owns 909,691 shares of Class A Common Stock.
  • He also indirectly owns 4,595 shares through an LLC and 2,632,766 shares through a trust.
  • Scaringe continues to hold options for 8,285,263 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral. The filing simply reports transactions executed under a pre-existing plan. There's no inherent positive or negative signal, but the market may interpret the sale as a lack of confidence, even if it's pre-planned.

Industry Context

Insider transactions are common, and the use of a 10b5-1 plan suggests the sales were pre-planned to avoid accusations of trading on inside information. The CEO's actions are being closely watched by investors as an indicator of confidence in the company's future prospects.

Comparison to Industry Standards

  • Comparing Scaringe's actions to other EV company executives, it's common to see similar transactions executed under 10b5-1 plans.
  • For example, executives at Tesla (TSLA) and Lucid (LCID) have also utilized such plans for stock sales and option exercises.
  • The scale of the transactions is relatively modest compared to some of the larger insider sales seen at more mature tech companies.
  • The fact that Scaringe retains a significant stake in Rivian, both directly and through options, is a positive sign for investors.

Stakeholder Impact

  • The transactions could influence investor sentiment, potentially affecting the stock price.
  • The CEO's continued significant stake in the company should reassure stakeholders.

Key Dates

DateDescription
February 14, 2023Stock option was fully vested
March 8, 2024Reporting Person adopted a Rule 10b5-1 trading plan
May 7, 2024Issuer's Quarterly Report on Form 10-Q for the three months ended March 31, 2024, filed with the SEC
July 12, 2024Date of transaction: Exercise of stock options and sale of shares
July 16, 2024Date of Form 4 filing
March 15, 2029Expiration date of stock options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.